Sex differences in the role of phospholipase A2-dependent arachidonic acid pathway in the perivascular adipose tissue function in pigs by Ahmad, Abdulla A. et al.
1Sex differences in the role of phospholipase A2-dependent arachidonic1
acid pathway in the perivascular adipose tissue function in pigs.2
Abdulla A Ahmad, Michael D Randall and Richard E Roberts3
Cell Signalling and Pharmacology Research Group, School of Life Sciences, University4
of Nottingham Medical School, Queen's Medical Centre, Nottingham NG7 2UH, United5
Kingdom.6
Abdulla A Ahmad: PhD student, Faculty of Medicine & Health Sciences7
Richard E Roberts: PhD, Lecturer in Pharmacology, Faculty of Medicine & Health8
Sciences9
Michael D Randall: PhD, Professor of Pharmacology, Faculty of Medicine & Health10
Sciences11
Corresponding author: Michael D Randall,12
Room E21, The University of Nottingham,13
Medical School14
Nottingham15
NG7 2UH16
UK17
Fax number: 0115 82 3014218
Telephone number: 0115 82 3018519
Email: michael.randall@nottingham.ac.uk20
Total word count: 635121
2Key Points:1
 The fat surrounding blood vessels (perivascular adipose tissue or PVAT)2
releases vasoactive compounds that regulate vascular smooth muscle tone.3
4
 There are sex differences in the regulation of vascular tone. However, to date, no5
study has investigated whether there are sex differences in the regulation of6
blood vessel tone by PVAT.7
8
 This study has identified that the cyclooxygenase products thromboxane and9
PGF2α are released from coronary artery PVAT from pigs. Thromboxane10
appears to mediate the PVAT-induced contraction in arteries from females,11
whereas PGF2α appears to mediate the contraction in arteries from males.12
13
 These sex differences in the role of these prostanoids in the PVAT-induced14
contraction can be explained by a greater release of thromboxane from PVAT15
from female animals and greater sensitivity to PGF2α in the porcine coronary16
artery from males.17
18
19
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3Abstract1
Previous studies have demonstrated that perivascular adipose tissue (PVAT) causes2
vasoconstriction. In this present study, we determined the role of cyclooxygenase-3
derived prostanoids in this contractile response and determined whether there were any4
sex differences in the regulation of vascular tone by PVAT. Contractions in isolated5
segments of coronary arteries were determined using isolated tissue baths and isometric6
tension recording. Segments were initially cleaned of PVAT, which was then re-added7
to the tissue bath and changes in tone measured over 1 hour. Levels of PGF2α and8
thromboxane B2 (TXB2) were quantified by ELISA and PGF2α (FP) and thromboxane9
A2 (TP) receptor expression determined by Western blotting. In arteries from both male10
and female pigs, re-addition of PVAT caused a contraction, which was partially11
inhibited by the cyclooxygenase inhibitors indomethacin and flurbiprofen. The FP12
receptor antagonist AL8810 attenuated the PVAT-induced contraction in arteries from13
males, whereas the TP receptor antagonist GR32191B inhibited the PVAT-induced14
contraction in arteries from females. Although there was no difference in PGF2α levels15
in PVAT between females and males, PGF2α produced a larger contraction in arteries16
from males, correlating with a higher FP receptor expression. In contrast, release of17
TXB2 from PVAT from females was greater than from males, but there was no18
difference in the contraction by the TXA2 agonist U46619, or TP receptor expression in19
arteries from different sexes. These findings demonstrate clear sex differences in PVAT20
function in which PGF2α and TXA2 antagonists can inhibit the PVAT-induced21
vasoconstriction in male and female PCAs, respectively.22
Abbreviations23
COX, cyclooxygenase; FP, PGF2α receptor; MLC, myosin light chain; PCA, porcine24
coronary artery; PGF2-α, prostaglandin F2-α; PLA2, phospholipase A2; PVAT,25
perivascular adipose tissue; TP, TXA2 receptor; TXA2, thromboxane A2.26
27
4Introduction1
Perivascular adipose tissue (PVAT) is positioned around blood vessels and is regarded2
as being distinct from the adventitia, in spite of an absence of a barrier between them.3
Compelling evidence in recent years has led to the view that PVAT is in fact an active4
secretory tissue which releases several bioactive signalling molecules, collectively5
termed adipokines, which are important in the control of vascular tone in both health6
and diseases (Fortuno et al., 2003; Havel, 2004; Thalmann & Meier, 2007; Yamawaki7
et al., 2010). Several studies have suggested a vasorelaxant or, at least, anticontractile8
effect of various fat depots in the body, proposing a role for TNF-α, H2S, NO,9
adiponectin and other adipocyte-derived relaxant factors (ADRFs) (Gao et al., 2007;10
Fang et al., 2009; Lynch et al., 2013; Virdis et al., 2015). On the other hand, other11
studies have reported opposing effects of PVAT on vascular tone. Gao et al. (2006)12
proposed that PVAT could augment vasoconstriction induced by perivascular nerve13
stimulation of the rat superior mesenteric artery. They reported that superoxide14
production from NAD(P)H oxidase (Gao et al., 2006) and angiotensin II (Lu et al.,15
2010) are involved in PVAT-mediated potentiation of perivascular nerve stimulation-16
elicited contraction. Prostanoids are cyclooxygenase metabolites of arachidonic acid17
(AA) that exert diverse physiological and pathological effects in different systems,18
including relaxation and contraction of vascular smooth muscle (VSM) (Wright et al.,19
2001). According to their selectivity for the natural prostanoids, prostaglandins (PG)20
PGI2, PGD2, PGE2, PGF2 and thromboxane A2 (TXA2), there are five main types of21
prostanoids receptors IP, DP, EP, FP and TP, respectively. Of these receptors, TP, and22
FP have the ability to mediate vasocontraction, IP and DP generally mediate23
vasorelaxation while depending on receptor subtype, EP has the ability to induce both24
contraction (EP1 and EP3) and relaxation (EP2 and EP4) (Coleman et al., 1994).25
Prostanoids released from PVAT have been shown to regulate vascular tone. For26
example, PGE2 and PGI2 released from PVAT surrounding human saphenous vein27
attenuates noradrenaline-induced contraction (Ozen et al., 2013). Similarly, prostacyclin28
released from mouse carotid artery PVAT exerts vasorelaxant effects and protects29
against endothelial dysfunction (Chang et al., 2012). In contrast, another study showed30
that aortic PVAT from mice is capable of releasing a cyclooxygenase (COX)-derived31
5adipocyte derived contracting factor (ADCF) that becomes functionally of greater1
activity in obesity (Meyer et al., 2013), although the identity of this COX metabolite is2
unknown.3
Extensive epidemiological data have revealed the existence of a prominent sexual4
dimorphism in the incidences of primary vascular diseases that involve excessive5
vasoconstriction. Thus, among the strongest independent risk factors for coronary artery6
disease is male sex and a male to female ratio of approximately 2:1 is consistently7
observed (Nettleship et al., 2009). In contrast, migraine headache (Bartelink et al.,8
1993) and Raynaud’s Disease (Voulgari et al., 2000) all occur in premenopausal women9
at rates as much as fourfold higher than in men. Furthermore, a previous study has10
indicated that oestrogen could upregulate the expression of COX-2 and thromboxane11
synthase in both endothelium and vascular smooth muscle, and upregulate the12
expression of TP receptors in smooth muscle of female rat aorta, leading to enhanced13
vasoconstrictor prostanoid function (Li et al., 2008). However, to date, no study has14
determined whether there are sex differences in the regulation of vascular tone by15
PVAT.16
In the porcine coronary artery, PVAT induces a contraction and enhances agonist and17
electrical field-stimulated contractile responses (Owen et al., 2013). However, the18
contractile agents involved in these responses are unknown. PVAT is a potential19
therapeutic target for controlling coronary artery tone. Therefore, in this present study,20
we determined whether cyclooxygenase-derived vasoconstrictor prostanoids play a role21
in PVAT-induced contractile responses and investigated whether there are sex22
differences in the response of the coronary artery to PVAT.23
24
6Methods1
Preparing of rings of porcine coronary arteries2
Hearts from male and female pigs (large white hybrid pigs, 4-6 months old, weighing ~3
50kg) were obtained from a local abattoir and transported back to the laboratory in ice-4
cold modified Krebs’-Henseleit solution (118 mM NaCl, 4.8 mM KCl, 1.1 mM MgSO4,5
25 mM NaHCO3, 1.2 mM KH2PO4, 12 mM D-glucose, 1.25 mM CaCl2). The anterior6
proximal part of the coronary artery was then dissected and placed in Krebs’-Henseleit7
solution pre-gassed with 5% CO2 and 95% O2. PVAT was carefully removed and8
maintained in Krebs’-Henseleit solution until further use. Thereafter, coronary arteries9
were cut into rings of approximately 5mm in length and suspended in a multichannel 510
ml organ bath setup. Each bath was filled with 5 ml of Krebs’-Henseleit solution and11
maintained at 37oC and constantly gassed with carbogen (95% O2, 5% CO2). Tension12
was measured and recorded using isometric force transducers connected to a Powerlab13
data acquisition system (ADInstruments) via an amplifier.14
Characterization of Vascular Responses of Porcine Isolated Coronary arteries15
The arteries were initially set to 8 g of tension, determined from preliminary studies,16
and then left to equilibrate for approximately 30-45 minutes. Once a stable baseline was17
attained, two consecutive responses to 60 mM KCl were obtained for standardization.18
Relevant test compounds were then added with 60 minutes incubation time. The19
following test compounds were used: melittin (10µM) to stimulate PLA2 activity20
(Koumanov et al., 2003); indomethacin (10µM) (Malinowski et al., 2008) and21
flurbiprofen (10µM) (Stanley & O'Sullivan, 2014) to determine the role of22
cyclooxygenase. To study the role of specific prostanoids, GR32191B (3µM) (He &23
Yang, 1999) and AL8810 (10µM) (Ramos-Alves et al., 2012) were used as antagonists24
of TP and FP receptors, respectively. Ethanol or DMSO (0.1% v/v) were used as vehicle25
controls, as appropriate. Of note, there was no obvious difference in the amount of26
PVAT per unit length of coronary artery between female and male. After incubation of27
the coronary artery segments with test compounds, 0.3 g PVAT was added to the organ28
baths and contractile responses measured.29
7In a separate series of experiments, cumulative concentration-response curves to the1
TXA2 agonist U46619 (1nM-300nM) or PGF2-α (0.1-100µM) were constructed in2
coronary artery segments from male and female pigs.3
Determination of levels of TXB2 and PGF2-α by ELISA.4
Levels of TXB2, a stable metabolite of TXA2, and PGF2-α in PVAT were determined by5
ELISA. PVAT (0.3g) was homogenised in either 0.1M potassium phosphate buffer [pH6
7.4] for TXB2 estimation, or Tris-buffered saline containing 0.1% v/v Tween 20 for7
PGF2-α estimation, along with protease inhibitor cocktail (Calbiochem) and8
indomethacin (10µM). The amount of TXB2 and PGF2-α in PVAT samples from male9
and female animals was analysed by ELISA (ab133022; ab133041), according to the10
instructions of the manufacturer. TXB2 and PGF2-α were detected colourimetrically11
using an alkaline phosphatase (AP) conjugated- secondary antibody with para-12
Nitrophenylphosphate (pNpp) as substrate. Colour intensity produced was determined13
by reading at 405 nm using a SpectraMAX 340 PC microplate reader (Molecular14
Devices, 50 Wokingham, Berkshire, UK). The results were expressed as pg µg-1 of total15
protein.16
Assessment of the PVAT-released TXB2 by ELISA.17
Porcine coronary arterial PVAT from each sex was dissected, weighed and added to an18
Eppendorf tube containing 1ml pre-gassed Krebs’-Henseleit solution, at 37oC. For19
consistency with the functional studies, PVAT was incubated for 2½hr with and without20
melittin (10µM) in order to investigate the effect of activation of PLA2 on the level of21
TXB2 released from PVAT. The level of TXB2 in the Krebs’-Henseleit solution was22
then determined using ELISA (as described above) and the data normalized for weight23
of PVAT.24
Estimation of TP and FP receptor expression in coronary arteries by Western25
immunoblotting.26
Western immunoblotting was performed to determine the expression of TP and FP27
receptors in segments of coronary arteries from female and male pigs. Arteries were28
finely dissected from the adherent PVAT and connective tissue and homogenized on ice29
using Tris buffer [pH 7.4] with protease inhibitor cocktail (Calbiochem, VWR30
8International Ltd, Lutterworth, Leicestershire, UK). After estimation of the protein1
content of each sample using the Lowry method, 6x Laemmli sample buffer was added2
to the samples. Samples were subsequently boiled at 100oC for 5 min and centrifuged3
at 13000×g for 1 min. Stock solutions (20µg per well) were run on 4–20% gradient4
polyacrylamide gradient gels (Bio-Rad, Hemel Hempstead, Hertfordshire, UK).5
Proteins were then transferred onto nitrocellulose membrane (GE Healthcare, Little6
Chalfont, Buckinghamshire, UK) by Western blotting, and then the membrane blocked7
with 5% (w/v) non-fat milk in Tris-buffered saline containing 0.1% v/v Tween 208
(TBST) at room temp for 1 h. The blot was then incubated with either rabbit anti-TXA29
receptor antibody (1:250 dilution; ab188897, Abcam, Cambridge, UK) or rabbit anti-10
PGF2-α receptor antibody (1:250 dilution; orb185891, Biorbyt, Cambridge, UK) in 5%11
milk in TBST overnight at 4°C with shaking. An anti-mouse myosin light chain (MLC)12
antibody was also included as a loading control (1:1000 dilution; Sigma-Aldrich, Poole,13
Dorset, UK). The following day, the blot was washed in TBST followed by incubation14
for 1 hour with IRDye 800CW goat anti rabbit (1:10,000) and IRDye 680CW goat anti-15
mouse (1:10,000) secondary antibodies (IRDye, Licor, Cambridge, UK). Immunoblot16
was then visualized using an Odyssey system from Licor.17
Materials18
All drugs were purchased from Sigma-Aldrich except for AL8810 from Santa Cruz19
Biotechnology and PGF2-α from Cayman Chemicals. Stock solutions of flurbiprofen,20
PGF2-α and GR32191B were dissolved in dimethyl sulfoxide (DMSO). Stock solution of21
indomethacin and AL8810 were dissolved in absolute ethanol whereas melittin was22
dissolved in distilled water. Stock solutions of U46619 were made to 10mM in ethanol.23
All further dilutions of the stock solutions were made using distilled water.24
Statistical analysis25
Data are expressed as mean ± S.E., where n = the number of different animals. The26
concentration-response curves were fitted to a sigmoidal curve with a variable slope27
using four parameters logistic equation using GraphPad Prism software. The maximum28
percentage contraction (Rmax) and the negative log of concentration required to produce29
half the maximal contraction of the induced tone (pEC50) were calculated from the fitted30
9curves. Data were tested for Normality using a Shapiro-Wilk test. Comparisons between1
two groups of data were analysed using 2-tailed, paired or unpaired Student’s t-test, as2
appropriate. The effects of enzyme inhibitors and receptor antagonists on the PVAT-3
induced contraction over time were analysed using a two-way ANOVA in conjunction4
with the Sidak’s post-hoc test to assess possible difference at individual concentrations.5
A p value <0.05 was considered to be statistically significant. Statistical analysis was6
performed by GraphPad Prism (Version 6).7
8
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Results1
Effects of addition of PVAT on vascular tone of female and male PCAs.2
Addition of 0.3 g PVAT caused a time-dependent increase in tone compared to time3
controls in coronary artery segments from both female and male PCAs (Figure 1). There4
was inter-individual variation in the size of the contractile response to PVAT therefore5
adjacent coronary arterial segments from the same animal were always used as controls.6
7
Figure 1: PVAT-induced vasoconstriction. Increase in vascular tone over time following8
addition of PVAT (0.3g) in female (A) and male (B) porcine coronary arteries. Data are9
expressed as change in tone per gram weight and are mean ± SEM of 7(A)- 4(B) experiments.10
(C) Original traces of recording showing the response of female PCA to addition of PVAT.11
***P < 0.001, (2-way ANOVA followed by a Sidak’s post-hoc test) versus control values.12
Role of prostanoids in PVAT-induced contraction13
Addition of the cyclooxygenase inhibitors indomethacin and flurbiprofen (both 10µM)14
had no effect on basal tone. However, they caused a significant inhibition in the15
contraction to PVAT compared to control in both sexes (Figure 2). The thromboxane16
11
receptor antagonist GR32191B (3µM) caused a partial reduction in the PVAT-induced1
contraction in coronary arteries from female animals (Figure 3A), whereas the responses2
of coronary arteries from male animals to PVAT were unaffected by GR32191B (Figure3
3B). As the TP receptor antagonist had no effect on the PVAT contraction in males, we4
determined the effect of a FP receptor antagonist. In contrast to the effect of TP receptor5
antagonism, the FP receptor antagonist AL8810 had no significant effect on the PVAT-6
induced contraction in coronary arteries from female animals, but reduced the7
contraction in coronary arteries from male animals (Figure 3 C & D).8
9
Figure 2: Effect of COX inhibition on PVAT-induced vasoconstriction. Contractile response10
of the PCAs to PVAT (0.3g) in the absence (control) or presence of 10µM indomethacin (A &11
B) or 10µM flurbiprofen (C & D). Data are expressed as change in tone per gram weight and12
are mean ± SEM from arteries from 15 female (A & C) and 8 male (B & D) animals . *13
indicates P < 0.05, *** indicates P < 0.001, **** indicates P < 0.0001, (2-way ANOVA14
followed by a Sidak’s post-hoc test) versus control values.15
12
1
Figure 3: Effect of inhibition of TXA2 and PGF2α on PVAT-induced vasoconstriction.2
Effects of pre-incubation with GR32191B (3µM, 1hr) on the response of porcine coronary3
arteries to PVAT (0.3g) in female (A) and male (B) pigs. Effects of pre-incubation with AL88104
(10µM, 1hr) on PVAT-induced vasoconstriction in female (C) and male (D) pigs. Data are5
expressed as change in tone per gram weight and are mean ± S.E.M. of arteries from 5-6 female6
(A & C) and 6-7 male (B & D) animals. * indicates p<0.05, ** indicates p<0.01 and ***7
indicates p<0.001, two-way ANOVA followed by a Sidak’s post-hoc test versus control values.8
NS- not significant.9
Determination of the level of TXB2 and PGF2α in PVAT by ELISA10
In order to determine whether the differences in the role of TP and FP receptors in11
arteries from male and female animals could be due to differences in the content of12
thromboxane and PGF2α in the PVAT, levels of the stable thromboxane metabolite13
TXB2, and PGF2α in PVAT were determined by ELISA. Both TXB2 and PGF2α were14
detected in the PVAT from the coronary artery. However, there was no significant15
difference in the level of TXB2 or PGF2α in coronary artery PVAT from female and16
male animals (Figure 4).17
13
1
Figure 4: Comparison of the level of TXB2 and PGF2α in PVAT from both sexes.2
Comparison of the levels of the TXB2 and PGF2α between PVAT from female and male pigs3
determined by ELISA. Data are expressed as pg per ml per µg protein concentration and are4
mean ± S.E.M. of PVAT from 5-7 female and 5-8 male animals (A-B).5
Determination of the level of TP and FP receptor expression in PCAs6
As there were no differences in the levels of TXB2 or PGF2α in PVAT from male and7
female animals, we determined whether there were differences in the expression of the8
receptors on the coronary artery, which might explain the differences in the role of these9
prostanoids. Western immunoblotting for the TP receptor identified a band at the10
predicted molecular weight of 40kDa. When expressed as a ratio to myosin light chains,11
used as a loading control, there was no difference in the level of expression of TP12
receptor between coronary arteries from male and female animals (Figure 5 A & B).13
Western immunoblotting also detected a band at 50kDa for the FP receptor. In this case,14
there was a significantly higher level of expression of the FP receptor in coronary15
arteries from male animals compared to female animals (Figure 5 D & E).16
Assessment of the responsiveness of PCAs to TXA2 and PGF2α 17
As our data indicate differences in the role of TP and FP receptors in the PVAT-induced18
contractions in coronary arteries from male and female animals, which cannot be19
explained by differences in the content of thromboxane and PGF2α in the fat, we20
determined whether there are differences in the contractions in response to TP or FP21
receptor activation, in the absence of PVAT. There was no difference in the response of22
14
PCAs to the TXA2 mimetic U46619 between female and male pigs (Figure 5C). On the1
other hand, the contractile responses to PGF2α were significantly greater in arteries from2
male pigs (Figure. 5F).3
4
5
Figure 5: Comparison of the expression of TP and FP receptors, and the responsiveness of6
PCAs to TXA2 and PGF2α in both sexes. A. Western immunoblot showing expression of TP7
receptor (40 kDa) and MLC (20 kDa) levels in 20 µg of coronary arteries from 6 female and 88
male pigs. B. Bar chart showing expression levels of TP receptor expression as a percentage of9
MLC expression in coronary arteries from male and female pigs based on the intensities of their10
bands. C. Log concentration-response curves to the thromboxane receptor agonist U46619 in11
porcine coronary artery segments from female and male. Data are expressed as change in tone12
per gram weight and are mean ± S.E.M. of 12 female and 9 male arteries. D. Western13
immunoblot showing expression of FP receptor (50 kDa) and MLC (20 kDa) levels in 20 µg of14
coronary arteries from 7 female and 8 male pigs. E. bar chart showing PGF2-α receptor 15
expression as a percentage of MLC expression in coronary arteries from male and female pigs16
based on the intensities of their bands. F. contractile response to serial concentrations of PGF2α 17
15
(0.1-100µM). Data are expressed as change in tone per gram weight and are means ± SEM of 101
Female and 7 male coronary arteries. Data are expressed as mean ± SEM, * indicates p<0.05, **2
indicates p<0.01, (two-tailed, unpaired Student’s t-test).3
Effect of phospholipase A2 stimulation on PVAT-induced contractions4
Our data indicate that cyclooxygenase produced prostanoids play a role in the PVAT-5
induced contraction in the porcine coronary artery. In order to support these data6
further, we investigated the effect of the phospholipase A2 (PLA2) stimulator melittin.7
Addition of melittin (10µM) at baseline tone produced a transient contraction of the8
arteries, returning to baseline within 15 minutes. Subsequent addition of PVAT led to a9
significant enhancement of the PVAT-induced contraction in mellitin- treated vessels10
compared with that of PVAT alone in coronary artery segments from both sexes (Figure11
6). The TP antagonist GR32191B caused complete inhibition of the PVAT-induced12
contraction in the presence of melittin in arteries from female animals and partial13
inhibition in arteries from male animals (Figure 6 C & D). Surprisingly, the FP receptor14
antagonist AL8810 had no effect on the PVAT-induced contractions in arteries from15
male or female animals (Figure 6 E & F). However, in subsequent experiments, we16
demonstrated that pre-incubation with melittin results in desensitisation of the FP17
receptor, but not TP receptor-mediated contraction as addition of U46619 and PGF2-α to18
the PCA after pre-incubation with melittin resulted in a contractile response to U4661919
but not PGF2-α (Figure 7 A & B).20
16
1
2
Figure 6 : Effect of phospholipase A2 stimulation on PVAT-induced contractions. A & B.3
Contractile responses of segments of porcine coronary arteries to fresh PVAT (0.3g) in the4
absence or presence of melittin (10μM). Data are expressed as change in tone per gram weight 5
and are mean ± SEM from arteries from 5 female (A) and 8 male (B) animals. C & D. Effect of6
pre-incubation with the TP receptor antagonist GR32191B (3µM) on the PVAT-induced7
contraction, in the absence or presence of melittin (10µM). Data are expressed as change in tone8
per gram weight and are means ± S.E.M. of 5 animals. E & F. Effect of pre-incubation with the9
FP receptor antagonist AL8810 (10µM) on the PVAT-induced contraction, in the absence or10
presence of melittin (10µM). Data are expressed as change in tone per gram weight and are11
17
means ± S.E.M. of 4 female (E) and 5 male (F) animals. * indicates p<0.05, ** indicates p<0.011
and ***indicates p<0.001, two-way ANOVA followed by a Sidak’s post-hoc test.2
3
Figure 7: Original traces of recording showing the vasomotor responses of PCA. A & B.4
Original traces of recording showing the response of melittin-stimulated female PCA to addition5
of 0.1µM U46619 and 1µM PGF2-α after PVAT pre-treatment (A and B, respectively). C & D.6
18
Original traces of recording showing the response of PCA to addition of 0.1µM U46619 and1
1µM PGF2-α (C and D, respectively).2
Determination of the release of TXB2 from PVAT3
Although there was no difference in the level of TXB2 in the PVAT from male and4
female animals, we explored the possibility that there are differences in the release of5
thromboxane from PVAT. Therefore, we determined the levels of TXB2 in the buffer6
after incubation with PVAT. In these experiments it was found that the concentration of7
TXB2 was higher in the buffer after incubation with PVAT from female animals8
compared to PVAT from male animals (Figure 8A). The level of TXB2 released from9
PVAT was significantly potentiated after addition of the PLA2 stimulator (melittin) in10
both females and males (Figure 8 B & C).11
12
19
1
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Figure 8 : Comparison of the release of TXB2 from PVAT in both sexes. A. Comparison of3
the levels of TXB2 in the buffer after incubation with PVAT from female or male pigs for 2.54
hours. Data are expressed as a pg of TXB2 released per ml per gm of PVAT and are mean ±5
S.E.M. of 10 female and – 9 male PVAT samples. * indicates p<0.05, 2-tailed, unpaired6
Student’s t-test. . B & C. Comparison of the levels of TXB2 in the buffer after a 2 ½ hours7
incubation with PVAT with and without melittin (10µM) from female (B) or male (C) pigs.8
Data are expressed as pg of TXB2 released per ml per gm of PVAT and are mean ± S.E.M. of 69
female and 7 male PVAT samples. * indicates p<0.05, ** indicates p<0.01, 2-tailed, paired10
Student’s t-test vs paired controls.11
12
20
Discussion1
The recognition that perivascular adipose tissue is not simply a reservoir for lipid2
storage but is also a complex endocrine organ, has led to a substantial research effort to3
establish the mechanistic links between the PVAT and vascular tone regulation. It is4
becoming increasingly clear that there are differences in the vascular responsiveness in5
males compared to females (Bubb et al., 2012). For example, we have identified6
differences in endothelial function between the sexes (Wong et al., 2015). In this7
present study, we have identified that the PVAT-induced contraction in the porcine8
coronary artery is mediated, at least in part, through the prostanoids thromboxane and9
PGF2α. Although both prostanoids are present in PVAT, there are sex differences in the10
vasomotor response of the coronary arteries to PVAT, in that TXA2 and PGF2α11
antagonists reduced the PVAT-induced vasoconstriction in females and males,12
respectively.13
Re-addition of PVAT to segments of porcine coronary artery produced a14
contractile response, which is in line with previous studies, indicating that coronary15
artery PVAT releases adipose-derived contractile factors (ADCFs) (Owen et al., 2013).16
However, this previous study did not identify the factor causing the contractile17
response. In this present study, we have demonstrated that the contraction in response to18
re-addition of PVAT was partially inhibited by cyclooxygenase inhibitors, indicating a19
role for contractile prostanoids. Furthermore, the contraction was inhibited by20
prostanoid receptor antagonists, providing further support for prostanoids in the21
contractile response. Interestingly, the contractile response to coronary artery PVAT22
from female animals was inhibited by a TP receptor antagonist, whereas the contractile23
response to coronary artery PVAT from male arteries was inhibited by a FP receptor24
antagonist. These data suggest sex differences in the prostanoids mediating the25
contractile response.26
The role of a cyclooxygenase product in the PVAT-induced contraction is27
similar to that seen in mouse aorta, although in that particular study, only thromboxane28
levels were measured (Meyer et al., 2013). In this present study we have demonstrated29
the presence of thromboxane in the PVAT from the porcine coronary artery, although30
there was no difference in the levels of this prostanoid between male and female31
21
animals. In addition, a concentration-response curve with a TXA2 agonist (U46619) was1
performed to assess the responsiveness of PCAs to TXA2 in both sexes and showed no2
difference in the response of coronary rings from different sexes to TXA2. Moreover,3
Western blot analysis found no difference in TP expression between female and male4
coronary arteries. These data indicate that the sex differences in the role of thromboxane5
in the PVAT-induced contraction cannot be attributable to either differences in TP6
receptor expression or coupling of the receptor to intracellular signalling pathways7
mediating contraction. We therefore determined whether there are differences in the8
release of thromboxane from the PVAT by measuring the levels of TXB2 in the buffer.9
Interestingly, there was a greater amount of TXB2 in the buffer containing PVAT from10
female animals compared to males, suggesting that, although levels of thromboxane are11
the same in PVAT from both sexes, a greater amount of thromboxane is actually12
released from the PVAT in females. Although the exact reason for the difference in13
release of TXB2 has not been addressed in this study, many reasons could be speculated14
such as the difference of the expression or function of TXB2 transporters (for example,15
multidrug resistance protein 4 or other prostaglandin transporters) which act as a16
prostanoid efflux pumps (Schuster, 2002; Reid et al., 2003; Rius et al., 2005) or17
differences in the turnover of released TXB2. However, the data explain why the PVAT-18
induced contraction in coronary arteries from female animals is inhibited by the TP19
receptor antagonist.20
The present study also provides evidence that PGF2α is expressed in the PVAT21
of the coronary artery and is involved in the PVAT-induced contraction in male pigs as22
FP receptor antagonism by AL8810 significantly reduced the resultant vasocontraction.23
Therefore, like thromboxane, PGF2α has a role as a PVAT-derived contractile agent.24
Although there was no difference in the level of PGF2α in the PVAT from male and25
female pigs, PGF2α itself produced a greater contractile response in coronary arteries26
from male animals compared to females. This corresponds with a greater expression of27
the FP receptor in coronary arteries from male animals. Therefore, the sensitivity of the28
PVAT-induced contraction to FP receptor antagonism in coronary arteries from male29
animals, but not females, could be explained by differences in FP receptor expression.30
22
In order to confirm the role of prostanoids in the PVAT-induced contraction in1
the coronary artery, we determined the effect of the PLA2 activator melittin. Melittin2
enhanced the PVAT-induced contraction in coronary arteries from both sexes, which3
correlates with the role of the PLA2-arachidonic acid- cyclooxygenase pathway.4
Furthermore, melittin enhanced the production of thromboxane within PVAT and the5
level of thromboxane released from the PVAT. Antagonism of TP receptors inhibited6
the contraction to PVAT in coronary arteries from both male and female animals.7
Interestingly, the FP antagonist no longer inhibited the PVAT-induced contractions in8
either male or female arteries. However, we found that melittin caused desensitisation of9
the PGF2-α contraction but not the TXA2,-induced contraction, as there was no10
contraction to PGF2-α in PCA segments pre-incubated with melittin, whereas the11
contraction to the thromboxane mimetic U46619 was maintained. This finding which12
could explain the lack of effect of the FP antagonist under these conditions. We13
hypothesise that this desensitisation is caused by release of PGF2-α from the coronary14
artery in response to melittin.15
A limitation of our study is the potential selectivity of GR32191B for TP16
receptors over FP receptors. However, our data indicate that the larger inhibition of the17
PVAT response seen with AL8810 in PCAs from males is likely to be due to greater18
responsiveness and FP receptor expression in males compared to females. Similarly, the19
greater effect of GR32191B on PVAT responses in females compared to males appears20
to be due to greater release of thromboxane.21
In conclusion, these data demonstrate that PVAT is able to regulate porcine22
coronary arterial tone through the release of thromboxane and PGF2α. To the best of our23
knowledge, this is the first study that identifies sex differences in PVAT-induced24
regulation of vascular tone, where thromboxane antagonist could inhibit thePVAT-25
dependant vasoconstriction in females while PGF2α antagonist is able to inhibit the26
contraction of PCAs from males. The variation of role TXA2 and PGF2α in different27
sexes is further supported by the findings of a greater release of thromboxane from28
PVAT from female animals and greater expression of FP receptors on the porcine29
coronary artery from males. It is clear that there are sex differences in the regulation of30
vascular tone, including the role of endothelium-derived hyperpolarization (EDH)31
23
(Wong et al., 2014). The data presented here enhance our knowledge of the mechanisms1
underlying these sex differences by demonstrating differences in the adipose-derived2
contractile factors released from coronary artery PVAT. Adipose tissue, including3
PVAT, changes under pathological conditions such as obesity. In the porcine coronary4
artery, obesity enhances the contractile responses of PVAT (Owen et al., 2013).5
Whether this is due to altered release of prostanoids is unknown. Furthermore, whether6
the sex difference in the release of prostanoids is maintained in obesity is unknown.7
Future studies should explore whether these sex differences in PVAT are maintained8
under pathological conditions.9
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